Antithrombotic efficacy of inactivated active site recombinant factor VIIa is shear dependent in human blood

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 3049-3056

  Ørvim, Una ^a   Marius Barstad, R ^a   Oørning, Lars ^a   Petersen, Lizette B ^a   Ezban, Mirella ^b   Hedner, Ulla ^b   Sakariassen, Kjell S ^a  

^a NYCOMED IMAGING AS   (Norway)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Blood flow; DEGR rFVIIa; Thrombus formation; Tissue factor

Indexed keywords

DANSY GLUTAMYL GLYCYL ARGINYL RECOMBINANT BLOOD CLOTTING FACTOR 7A; FIBRIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BLOOD FLOW; DRUG EFFICACY; HUMAN; MORPHOMETRICS; NORMAL HUMAN; PRIORITY JOURNAL; SHEAR RATE; THROMBOSIS;

EID: 17344362233     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.3049     Document Type: Article

References (12)

1. Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a "Prima Ballerina" Thromb Haemost. 1995;74:7-17.
2. Weiss HJ, Turitto VT, Baumgartner HR, Nemerson Y, Hoffmann T. Evidence for the presence of tissue factor activity on subendothelium. Blood. 1989;73:968-975.
3. Jang IK, Gold HK, Leinbach RC, Fallon JT, Collen D, Wilcox JN. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb. 1992;12:948-954.
4. Kirchhofer D, Sakariassen KS, Clozel M, Tschopp TB, Hadváry P, Nemerson Y, Baumgartner HR. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood. 1993;81:2050-2058.
5. Salatti JA, Anton P, Nemerson Y, Sakariassen KS. Modulation of procoagulant activity of extracellular endothelial matrix by antitissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val: experiments with flowing non-anticoagulated human blood. Blood Coagul Fibrinol. 1993;4:881-890.
6. Barstad RM, Hamers MJAG, Kierulf P, Westvik AB, Sakariassen KS. Procoagulant human monocytes mediate tissue factor/factor Vila-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood. Arterioscler Thromb Vasć Biol. 1995;15:11-16.
7. Diquélou A, Dupouy D, Gaspin D, Constans J, Sié P, Boneu B, Sakariassen KS, Cadroy Y. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions. Thromb Haemost. 1995;74:778-783.
8. Levi M, ten Gate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, van Deventer SJH, Hack CE, ten Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994;93:114-120.
9. Haskel EJ, Torr SR, Day KG, Palmier MO, Wun TC, Sobel BE, Abendschein DR. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation. 1991;84:821-827.
10. Lindahl AK, Sandset PM, Thune-Wiiger M, Nordfang O, Sakariassen KS. Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix. Blood Coag Fibrinol. 1994;5:755-760.
11. Krishnaswamy S. The interaction of human factor VIIa with tissue factor. J Biol Chem. 1992;267:23696-23706.
12. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 1994;8:385-390.